RMB advised Mediclinic on its R8.4-bn acquisition of a 29.9% stake in LSE listed Spire Healthcare Group plc and R10-bn rights issue.
RMB advised Mediclinic on its R32-bn reverse take-over of Abu Dhabi-based Al Noor Hospitals Group plc and primary listing on the London Stock Exchange.
As mandated lead arranger and sustainability agent, RMB supports Mediclinic’s sustainability journey into the future.
RMB acted as advisor and sponsor to Sanlam in its acquisition of a majority shareholding in AfroCentric. This transaction will add strong healthcare capabilities to Sanlam’s already broad offering.
RMB, leveraging parent company FirstRand’s SPIRE fund, facilitated a project to upgrade a general ward to a Medical Acute Care Unit at Chris Hani Baragwanath Academic Hospital.
Africa’s population growth is expected to rise, resulting in an increased need for high quality, accessible healthcare and a requirement to service the future tourism and hospitality demand across the continent.